Literature DB >> 1789689

The use of hospital discharge data for public health surveillance of Guillain-Barré syndrome.

T J Koobatian1, G S Birkhead, M M Schramm, R L Vogt.   

Abstract

The sensitivity of passive reporting of Guillain-Barré syndrome (GBS) to the Vermont Department of Health from 1980 to 1985 was compared to that of computerized hospital discharge abstract data. Written hospital discharge summaries were reviewed for clinical data to validate the computerized abstracts. In all, 51 definite and probable cases of GBS were identified from hospital data during a period when only 4 cases (8%) had been reported to the health department through passive physician reporting. Based on the hospital data, the incidence of this syndrome in Vermont was 1.6/100,000 population/year. The incidence rate for males was 1.5 times that for females. No geographical or seasonal clustering of cases was found. These epidemiological features are consistent with previously published data on the syndrome and suggest that the incidence has not changed significantly in the past 10 years. Incidence rates for GBS based on passively reported cases markedly underestimate the true incidence rate. Although limited by the lack of timeliness for public health surveillance, computerized hospital discharge data are readily available in many states and may be more sensitive in detecting cases, compared to passive surveillance. They may be a useful tool for establishing baseline rates and examining long-term trends for selected acute diseases like GBS for which there are well-established diagnostic criteria and that usually result in hospitalization.

Entities:  

Mesh:

Year:  1991        PMID: 1789689     DOI: 10.1002/ana.410300418

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Implementation and Evaluation of Guillain-Barré Syndrome Surveillance in Puerto Rico during the 2016 Zika Virus Epidemic.

Authors:  Chelsea G Major; Emilio Dirlikov; Nicole A Medina; Roberta Lugo-Robles; Desiree Matos; Jorge Muñoz-Jordán; Candimar Colón-Sánchez; Myriam García-Negrón; Marangely Olivero-Segarra; Graciela Malavé-González; Dana L Thomas; Carlos A Luciano; Stephen H Waterman; James Sejvar; Tyler M Sharp; Brenda Rivera-García
Journal:  P R Health Sci J       Date:  2018-12       Impact factor: 0.705

2.  The Guillain-Barrè syndrome (GBS). Implementation of a register of the disease on a nationwide basis. Italian GBS Study Group.

Authors:  E Beghi; G Bogliun
Journal:  Ital J Neurol Sci       Date:  1996-10

3.  Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

Review 4.  Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis.

Authors:  James J Sejvar; Andrew L Baughman; Matthew Wise; Oliver W Morgan
Journal:  Neuroepidemiology       Date:  2011-03-21       Impact factor: 3.282

5.  Guillain-Barré syndrome in Stockholm County, 1973-1991.

Authors:  G X Jiang; Q Cheng; A Ehrnst; H Link; J de Pedro-Cuesta
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

6.  Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-93.

Authors:  G X Jiang; Q Cheng; H Link; J de Pedro-Cuesta
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

7.  Epidemiological study of Guillain-Barré syndrome in south east England.

Authors:  J H Rees; R D Thompson; N C Smeeton; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

8.  Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.

Authors:  Matthew E Wise; Melissa Viray; James J Sejvar; Paige Lewis; Andrew L Baughman; Walter Connor; Richard Danila; Greg P Giambrone; Christa Hale; Brenna C Hogan; James I Meek; Rendi Murphree; John Y Oh; Arthur Reingold; Norisse Tellman; Susan M Conner; James A Singleton; Peng-Jun Lu; Frank DeStefano; Scott K Fridkin; Claudia Vellozzi; Oliver W Morgan
Journal:  Am J Epidemiol       Date:  2012-05-11       Impact factor: 4.897

9.  Guillain-Barré syndrome and antecedent cytomegalovirus infection, USA 2009-2015.

Authors:  Jessica Leung; James J Sejvar; Jesus Soares; Tatiana M Lanzieri
Journal:  Neurol Sci       Date:  2019-12-11       Impact factor: 3.307

Review 10.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.